| Overview |
| bs-1837R-Cy7 |
| KCNA5 Polyclonal Antibody, Cy7 Conjugated |
| WB |
| Human, Mouse, Rat, Dog, Cow, Pig, Chicken, Rabbit |
| Specifications |
| Cy7 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human KCNA5 |
| 551-613/613 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 3741 |
| P22460 |
| Cell membrane |
| HK2; HCK1; PCN1; ATFB7; HPCN1; KV1.5; Potassium voltage-gated channel subfamily A member 5; Voltage-gated potassium channel HK2; Voltage-gated potassium channel subunit Kv1.5; KCNA5 |
| Mediates the voltage-dependent potassium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a potassium-selective channel through which potassium ions may pass in accordance with their electrochemical gradient. This channel displays rapid activation and slow inactivation. May play a role in regulating the secretion of insulin in normal pancreatic islets. Isoform 2 exhibits a voltage-dependent recovery from inactivation and an excessive cumulative inactivation. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz